Keyphrases
Chemotherapy
100%
Tumor
100%
Nanotechnology
100%
Therapeutic Approaches
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Triple-negative Breast Cancer
100%
Overexpression
50%
Estrogen Receptor
50%
Breast Cancer
50%
Effective Treatment
50%
Lung
50%
Histology
50%
Response to Treatment
50%
Progesterone Receptor
50%
Breast Cancer Treatment
50%
Metastatic Lesions
50%
5-year Survival
50%
Targeted Therapy
50%
Brain Metastases
50%
Survival Rate
50%
Systemic Treatment
50%
Highly Aggressive
50%
Heterogeneous Groups
50%
Invasive Breast Cancer
50%
Metastatic TNBC
50%
Hormone-positive
50%
Ineffective Treatment
50%
1-year Survival
50%
2-year Survival
50%
Loss of Expression
50%
Anti-human Epidermal Growth Factor Receptor 2
50%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Breast Cancer
33%
Neoplasm
22%
Survival Rate
22%
Epidermal Growth Factor Receptor 2
22%
Gamma Urogastrone
22%
Cancer Therapy
11%
Targeted Therapy
11%
Brain Metastasis
11%
Estrogen Receptor
11%
Progesterone Receptor
11%
Systemic Therapy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
Breast Cancer
33%
Neoplasm
22%
Chemotherapy
22%
Survival Rate
22%
Epidermal Growth Factor Receptor 2
22%
Gamma Urogastrone
22%
Estrogen Receptor
11%
Brain Metastasis
11%
Systemic Treatment
11%
Progesterone Receptor
11%